Evidence map›Paper›PMID 42844391›Full record

ArticleEuropean radiology2026

Preoperative [

Xingyu Mu, Ge He, Xiaoqi Huang, Jingze Li, Denglu Lu, Zuguo Li, Wei Fu, Yanyun Deng

Abstract read
PubMed Publisher
In one paragraph

Article in European radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Xingyu Mu *Department of Nuclear Medicine, The First Affiliated Hospital of Guilin Medical University, Guilin, China.
Ge He *Department of General Surgery, Liuzhou Worker's Hospital, Liuzhou, China.
Xiaoqi Huang *Department of Nuclear Medicine, Liuzhou Worker's Hospital, Liuzhou, China.
Jingze LiDepartment of Nuclear Medicine, The First Affiliated Hospital of Guilin Medical University, Guilin, China.
Denglu LuDepartment of Nuclear Medicine, Liuzhou Worker's Hospital, Liuzhou, China.
Zuguo LiDepartment of Nuclear Medicine, The First Affiliated Hospital of Guilin Medical University, Guilin, China.
Wei FuDepartment of Nuclear Medicine, The First Affiliated Hospital of Guilin Medical University, Guilin, China. fuwei19700513@163.com.ORCID http://orcid.org/0009-0000-5173-6331
Yanyun DengDepartment of Nuclear Medicine, Liuzhou Worker's Hospital, Liuzhou, China. dyyee@163.com.

Funding

Guangxi Health Commission Z-B20241425Liuzhou Key Laboratory of Precision Detection and Clinical Translation in Colorectal Cancer Lgy-sys-2026007the National Natural Science Foundation of China 82402332the National Natural Science Foundation of China 82460356the Natural Science Foundation of Guangxi Zhuang Autonomous Region 2025GXNSFHA069001
6 · The paper itself

Abstract

objectivesTo determine whether preoperative [ MATERIALS AND

methodsThis retrospective dual-center study included consecutive adults who underwent [

resultsSixty-four patients (mean age, 63.8 years ± 9.4; 40 men) with 65 primary lesions were analyzed. Maximum standardized uptake value (SUV

conclusionPreoperative [ KEY POINTS: Question Can preoperative fibroblast activation protein inhibitor PET/CT identify colorectal cancer tumor budding, a clinically relevant marker of aggressive invasive-front biology? Findings Higher [

Indexed as

Cancer-associated fibroblastsColorectal neoplasmsNeoplasm gradingPositron-emission tomographyPredictive value of tests

Identifiers

PMID42844391

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.